IDEXX LABORATORIES INC /DE Cash and Cash Equivalents, Period Increase (Decrease)
IDEXX LABORATORIES INC /DE (IDXX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$63.88 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-15
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $18.66M, a 286.33% increase year-over-year.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $3.04M, a 65.92% decline year-over-year.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $5.57M, a 31.99% decline year-over-year.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $5.51M, a 39.10% increase year-over-year.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$63.88M, a 294.91% decline from fiscal 2017.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for fiscal 2017 was $32.77M, a 26.51% increase from fiscal 2016.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for fiscal 2016 was $25.91M.
- IDEXX LABORATORIES INC /DE cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$193.54M, a 545.15% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$63.88M 10-K · filed 2019-02-15 | |||
| 2017-12-31 | $18.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $21.70M derived: sum of 2 quarters · filed 2019-02-15 | $27.27M derived: sum of 3 quarters · filed 2019-02-15 | $32.77M 10-K · filed 2019-02-15 |
| 2017-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $8.61M derived: sum of 2 quarters · filed 2017-10-31 | $14.12M 10-Q · filed 2017-10-31 | $18.95M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $5.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $11.07M 10-Q · filed 2017-08-01 | $15.90M derived: sum of 3 quarters · filed 2019-02-15 | $24.84M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $5.51M 10-Q · filed 2017-04-28 | $10.34M derived: sum of 2 quarters · filed 2019-02-15 | $19.27M derived: sum of 3 quarters · filed 2019-02-15 | $27.45M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $13.76M derived: sum of 2 quarters · filed 2019-02-15 | $21.95M derived: sum of 3 quarters · filed 2019-02-15 | $25.91M 10-K · filed 2019-02-15 |
| 2016-09-30 | $8.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $17.12M derived: sum of 2 quarters · filed 2017-10-31 | $21.08M 10-Q · filed 2017-10-31 | $8.92M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $12.14M 10-Q · filed 2017-08-01 | -$11.00K derived: sum of 3 quarters · filed 2018-02-16 | -$22.01M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $3.96M 10-Q · filed 2017-04-28 | -$8.20M derived: sum of 2 quarters · filed 2018-02-16 | -$30.20M derived: sum of 3 quarters · filed 2018-02-16 | -$49.21M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$34.16M derived: sum of 2 quarters · filed 2018-02-16 | -$53.17M derived: sum of 3 quarters · filed 2018-02-16 | -$193.54M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$41.01M derived: sum of 2 quarters · filed 2016-11-01 | -$181.39M 10-Q · filed 2016-11-01 | -$151.59M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$19.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$159.38M 10-Q · filed 2016-08-02 | -$129.58M derived: sum of 3 quarters · filed 2017-02-17 | -$141.90M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$140.38M 10-Q · filed 2016-04-29 | -$110.58M derived: sum of 2 quarters · filed 2017-02-17 | -$122.89M derived: sum of 3 quarters · filed 2017-02-17 | -$104.04M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $29.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $17.49M derived: sum of 2 quarters · filed 2017-02-17 | $36.33M derived: sum of 3 quarters · filed 2017-02-17 | $43.48M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$12.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $6.53M derived: sum of 2 quarters · filed 2015-10-28 | $13.68M 10-Q · filed 2015-10-28 | $27.92M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $18.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $25.99M 10-Q · filed 2015-07-30 | $40.24M derived: sum of 3 quarters · filed 2016-02-17 | $54.03M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $7.14M 10-Q · filed 2015-04-28 | $21.39M derived: sum of 2 quarters · filed 2016-02-17 | $35.19M derived: sum of 3 quarters · filed 2016-02-17 | $57.84M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $14.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $28.05M derived: sum of 2 quarters · filed 2016-02-17 | $50.69M derived: sum of 3 quarters · filed 2016-02-17 | $55.07M 10-K · filed 2016-02-17 |
| 2013-09-30 | $13.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $36.45M derived: sum of 2 quarters · filed 2014-10-24 | $40.83M 10-Q · filed 2014-10-24 | $43.37M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $22.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $27.03M 10-Q · filed 2014-07-25 | $29.57M derived: sum of 3 quarters · filed 2015-02-17 | $49.20M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $4.38M 10-Q · filed 2014-04-25 | $6.92M derived: sum of 2 quarters · filed 2015-02-17 | $26.55M derived: sum of 3 quarters · filed 2015-02-17 | $42.87M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $22.17M derived: sum of 2 quarters · filed 2015-02-17 | $38.49M derived: sum of 3 quarters · filed 2015-02-17 | $40.09M 10-K · filed 2015-02-17 |
| 2012-09-30 | $19.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $35.95M derived: sum of 2 quarters · filed 2013-10-22 | $37.55M 10-Q · filed 2013-10-22 | $39.94M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $16.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $17.92M 10-Q · filed 2013-07-23 | $20.31M derived: sum of 3 quarters · filed 2014-02-18 | $42.41M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $1.60M 10-Q · filed 2013-04-23 | $3.99M derived: sum of 2 quarters · filed 2014-02-18 | $26.09M derived: sum of 3 quarters · filed 2014-02-18 | $32.03M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $24.50M derived: sum of 2 quarters · filed 2014-02-18 | $30.44M derived: sum of 3 quarters · filed 2014-02-18 | $26.98M 10-K · filed 2014-02-18 |
| 2011-09-30 | $22.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $28.04M derived: sum of 2 quarters · filed 2012-10-19 | $24.58M 10-Q · filed 2012-10-19 | $47.99M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $5.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | $2.48M 10-Q · filed 2012-07-20 | $25.89M derived: sum of 3 quarters · filed 2013-02-19 | $41.42M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | -$3.46M 10-Q · filed 2012-04-20 | $19.95M derived: sum of 2 quarters · filed 2013-02-19 | $35.48M derived: sum of 3 quarters · filed 2013-02-19 | $47.10M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $23.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $38.94M derived: sum of 2 quarters · filed 2013-02-19 | $50.56M derived: sum of 3 quarters · filed 2013-02-19 | $50.19M 10-K · filed 2013-02-19 |
| 2010-09-30 | $15.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $27.16M derived: sum of 2 quarters · filed 2011-10-21 | $26.78M 10-Q · filed 2011-10-21 | $26.78M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $11.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $11.25M 10-Q · filed 2011-07-22 | $11.25M derived: sum of 3 quarters · filed 2012-02-17 | $14.23M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | -$374.00K 10-Q · filed 2011-04-21 | -$374.00K derived: sum of 2 quarters · filed 2012-02-17 | $2.61M derived: sum of 3 quarters · filed 2012-02-17 | |
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.98M derived: sum of 2 quarters · filed 2012-02-17 | $27.86M 10-K · filed 2012-02-17 | |
| 2009-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | $27.86M 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | $24.88M 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | $18.51M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |